Chiron Biotech – Multimaterial Bioprinting

We are glad to announce the start of the Chiron project. The aim of the project is to create a smart multi material bioprinting platform for the research and production in the biomedical sector to create a portfolio of biomaterials and applications.

Chiron Biotech - Multimaterial Bioprinting

It officially started with the consortium team working on developing the bioprinter. Key milestones being the delivery of the full bioprinting platform to the University of Eindhoven and a special jetting equipment to Trinity College of Dublin.
Numerous applications are possible with our technology. This includes: multimaterial biofabrication, personalized medicine & drug discovery, regenerative medicine and bioprocessing, just to name a few. Therefore, we are excited to experience a world where this technology becomes part of scientific research and medicine.

While Chiron is funded by Eurostars, a European programme specifically dedicated to research performing SMEs, Chiron is an international collaboration between two SMEs (Concr3de BV and IPC – Innovative Polymer Compounds) and two research centers (University Medical Center of Utrecht and the Trinity College of Dublin).

Follow our new website https://chiron-biotech.com/ to stay up to date with the project development and milestones !

Ubiquitome – ubiquitous cloud connected, genetic analysis devices

Ubiquitome’s mission is to enable universal access to genomic information through ubiquitous cloud connected, genetic analysis devices.

Ubiquitome – ubiquitous cloud connected, genetic analysis devices

Ubiquitome

Continue reading

BioFunds.org – you can finance research for Free !

BioFunds.org – you can finance research for Free !

By using Biofunds for all your search on Google, PubMed or Protocols, you can help finance Science and Research ! For Free !

Continue reading

Cristal Therapeutics – next generation nanomedicines

Cristal Therapeutics is a clinical stage biopharma company developing the next generation nanomedicines based on its proprietary CriPec platform to treat various diseases, including cancer.

Cristal Therapeutics – next generation nanomedicines

cristal therapeutics Continue reading

PharmaCell – cell therapy and regenerative medicine CMO

PharmaCell is a leading European-based Contract Manufacturing Organization (CMO) exclusively focused in the area of cell therapy and regenerative medicine. PharmaCell has experience in supporting Phase I through Phase III clinical trials and early commercial manufacturing in cell therapy in terms of manufacturing, Quality Control, storage, in-outgoing logistics and product release.

PharmaCell – cell therapy and regenerative medicine CMO

PharmaCell

Continue reading

CiMaas – cellular immonotherapy

CiMaas BV is a biotech company developing cellular immunotherapy for specific groups of cancer patients. CiMaas focuses on the development of two unique products: a cancer vaccine using the patient’s own immune (dendritic) cells and the production of donor natural killer cells. These methods can help to treat many oncological diseases.

CiMaas – cellular immonotherapy

CiMaas Continue reading

SkylineDx – innovative signature-based diagnostic tests

SkylineDx is an innovative biotech company specialized in the development and commercialization of genetic tests.

SkylineDx – innovative signature-based diagnostic tests

skylinedx Continue reading

Amarna – next-generation viral vector platform

Amarna Therapeutics is biotech company developing a next-generation viral vector platform playing a key role in transforming treatment across many disease areas.

Amarna – next-generation viral vector platform

Amarna Continue reading